Loading...
154 Europe Chronic Disorder Drugs Reports
Country Covered: France
Study Period: 2019 - 2030
Major Players: Abbvie, Bioxis Pharmaceuticals, Dermaceutic Laboratoire, Ipsen, Sinclair Pharma
Region Covered: Europe
Study Period: 2019 - 2030
Countries Covered: Germany, United Kingdom, France, Italy, Spain
Major Players: Amgen, AstraZeneca, Bayer, Bristol-Myers Squibb, Roche
Country Covered: Russia
Study Period: 2019 - 2030
Major Players: AstraZeneca, Eli Lilly and Company, Boehringer Ingelheim, Novo Nordisk, Sanofi
Country Covered: Germany
Study Period: 2019 - 2030
Major Players: Novo Nordisk, Sanofi, AstraZeneca, Eli Lilly and Company, Merck
Country Covered: Italy
Study Period: 2019 - 2030
Major Players: Novo Nordisk, AstraZeneca, Boehringer Ingelheim, Sanofi, Eli Lilly and Company
Country Covered: United Kingdom
Study Period: 2019 - 2030
Major Players: AstraZeneca, Boehringer Ingelheim, Novo Nordisk, Sanofi, Eli Lilly and Company
Country Covered: France
Study Period: 2019 - 2030
Major Players: AstraZeneca, Boehringer Ingelheim, Sanofi, Novo Nordisk, Eli Lilly and Company
Region Covered: Europe
Study Period: 2019 - 2030
Countries Covered: United Kingdom, Germany, France, Russia, Spain, Italy
Major Players: Novo Nordisk, Sanofi, Eli Lilly and Company, AstraZeneca, Biocon
Country Covered: Spain
Study Period: 2019 - 2030
Major Players: Eli Lilly and Company, Boehringer Ingelheim, AstraZeneca, Sanofi, Novo Nordisk
Country Covered: Italy
Study Period: 2019 - 2030
Major Players: Sanofi, Eli Lilly and Company, Astellas Pharma, AstraZeneca, Janssen
Region Covered: Europe
Study Period: 2019 - 2030
Countries Covered: France, Germany, Italy, Russia, Spain, United Kingdom
Major Players: Sanofi, Eli Lilly and Company, AstraZeneca, Astellas Pharma, Janssen
Region Covered: Europe
Study Period: 2019 - 2030
Countries Covered: United Kingdom, Germany, Italy, Spain, France, Russia
Major Players: Eli Lilly and Company, AstraZeneca, Novo Nordisk, Sanofi, Boehringer Ingelheim
Region Covered: Europe
Study Period: 2019 - 2030
Countries Covered: France, Germany, Italy, Russia, Spain, United Kingdom
Major Players: Teva Pharmaceutical Industries, Bristol-Myers Squibb, AstraZeneca, Sanofi, Merck
Region Covered: Europe
Study Period: 2021 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Koninklijke Philips, Colgate-Palmolive Company, DMG Dental, VOCO, Dentsply Sirona
Region Covered: Europe
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Alcon, Bausch Health, Johnson & Johnson, Carl Zeiss, Topcon
Region Covered: Europe
Study Period: 2021 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: DermaMed Solutions, Abbvie, Obagi Cosmeceuticals, Merz Pharma, L'Oréal SA
Region Covered: Europe
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Medtronic, Astellas Pharma, Macleods Pharmaceuticals, Pfizer, AbbVie Ltd.
Region Covered: Europe
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Abbvie, Merck, Novartis, Bausch Health, Johnson & Johnson
Region Covered: Europe
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Takeda Pharmaceuticals, Bristol-Myers Squibb, Lupin, Accord Healthcare, Otsuka
Region Covered: Europe
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Novartis, Bristol-Myers Squibb, Incyte, Takeda Pharmaceuticals, Viatris
Region Covered: Europe
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Abbvie, AstraZeneca, Takeda Pharmaceuticals, Bausch Health, Johnson & Johnson(Janssen Global Services LLC)
Region Covered: Europe
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Evoke Pharma, AstraZeneca, Zydus Group, Neurogastrx, Abbvie
Region Covered: Europe
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Abbott Laboratories, Eli Lilly and Company, Teva Pharmaceutical Industries, Endo International, Ferring Pharmaceuticals
Region Covered: Europe
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Abbott Laboratories, AstraZeneca, GlaxoSmithKline, Johnson & Johnson, Pfizer
Region Covered: Europe
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Amgen, AstraZeneca, Roche, Eli Lilly and Company, GlaxoSmithKline
Region Covered: Europe
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Abbott Laboratories, Gilead Sciences, Novartis, Sanofi, Astellas Pharma
Region Covered: Europe
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Abbott Laboratories, Axogen, Medtronic, Boston Scientific, Integra LifeSciences
Region Covered: Europe
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Abbott Laboratories, GlaxoSmithKline, Johnson & Johnson, Novartis, UCB
Region Covered: Europe
Study Period: 2021 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Bausch Health, Roche, Mylan, Sun Pharmaceuticals Industries, Merck
Region Covered: Europe
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Abbvie, Merck, Pfizer, Exelixis, Viatris
Filter Reports
By Countries
